Skip to content
The Nexus
DossierENTITY

GLP1R

Coverage of GLP1R in the Nexus archive.

Earliest in view: Apr 8 · 00:00 UTCMost recent: May 6 · 00:00 UTC
Co-mentioned in this coverage
Natureorganization2Glucagon-like peptide 1 receptortopic1GIPRtopic1GLP-1topic1
Recent coverage
  • SCIENCEMay 6 · 00:00 UTCNATURE NEWS
    A brain reward circuit inhibited by next-generation weight-loss drugs in mice

    Researchers investigated the neural circuitry of small-molecule GLP1R agonists in humanized glucagon-like peptide 1 receptor mouse models. The study found that next-generation weight-loss drugs inhibit a brain reward circuit in mice. This discovery has implications for how these orally delivered weight-loss drugs engage brain reward circuits.

  • HEALTHApr 8 · 00:00 UTCNATURE NEWS
    Genetics reveal why people respond differently to GLP-1 weight-loss drugs

    A study published in Nature identifies genetic variants in GLP1R and GIPR genes as key factors influencing individual responses to GLP-1-based weight-loss drugs. These variants may explain varying drug effectiveness and potential adverse effects among patients.